Stock Events

Stock Events

Larimar Therapeutics (ZA71.F) Q3 2025 Earnings

14AugConfirmed

Q3 2024

Q4 2024

Q2 2025

Q3 2025

-0.41

-0.35

-0.28

-0.22

Details

Expected EPS

-0.41223425688000004

Actual EPS

-0.3519276

Surprise EPS

0.06

Surprise Percent

+14.63%

Description

Larimar Therapeutics (ZA71.F) has reported earnings of -0.3519276 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.